Skip to main content
LENSAR, Inc. (LNSR)
NASDAQ: LNSR · Real-Time Price · USD
11.97
+0.11 (0.93%)
At close: Feb 27, 2026, 4:00 PM EST
11.99
+0.02 (0.17%)
After-hours: Feb 27, 2026, 4:15 PM EST

LENSAR Revenue

LENSAR had revenue of $14.32M in the quarter ending September 30, 2025, with 5.74% growth. This brings the company's revenue in the last twelve months to $59.14M, up 21.02% year-over-year. In the year 2024, LENSAR had annual revenue of $53.49M with 26.87% growth.

Revenue (ttm)
$59.14M
Revenue Growth
+21.02%
P/S Ratio
2.42
Revenue / Employee
$422,436
Employees
140
Market Cap
142.98M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202453.49M11.33M26.87%
Dec 31, 202342.16M6.81M19.25%
Dec 31, 202235.36M899.00K2.61%
Dec 31, 202134.46M8.08M30.62%
Dec 31, 202026.38M-4.15M-13.58%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Inogen 348.67M
Treace Medical Concepts 218.88M
InfuSystem Holdings 143.44M
AVITA Medical 71.61M
Electromed 68.86M
Apyx Medical 47.90M
Baird Medical Investment Holdings 31.86M
Rapid Micro Biosystems 30.52M
Revenue Rankings

LNSR News

More News